Omeros (OMER) Asset Utilization Ratio (2011 - 2026)

Omeros' (OMER) quarterly Asset Utilization Ratio came in at 0.22 in Q1 2026, down 27.98% year-on-year from 0.31 in Q1 2025, and down 27.98% quarter-over-quarter from 0.31 in Q1 2025.

Omeros (OMER) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

Omeros has disclosed Asset Utilization Ratio across 13 years of filings, most recently posting 0.22 for Q1 2026.

  • Asset Utilization Ratio for Q1 2026 came in at 0.22, down 27.98% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.22 (down 27.98% YoY), and the FY2020 annual result was 0.46, down 51.65% from the prior year.
  • Asset Utilization Ratio came in at 0.22 for Q1 2026 at Omeros, down from 0.31 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.31 in Q1 2025 to a low of 0.22 in Q1 2026.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.55
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.60
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 1,422.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.47
9 Abivax 91.96 Bn 91.96 Bn - -
10 Omeros 737.87 Mn 602.55 Mn 9.31 Mn 0.22

Historic Data

Download Data
DateValue
Mar 31, 2026 0.22
Mar 31, 2025 0.31
Sep 30, 2021 0.67
Jun 30, 2021 0.56
Mar 31, 2021 0.42
Dec 31, 2020 0.36
Sep 30, 2020 0.65
Jun 30, 2020 1.06
Mar 31, 2020 0.89
Dec 31, 2019 0.98
Sep 30, 2019 1.11
Jun 30, 2019 0.79
Mar 31, 2019 0.51
Dec 31, 2018 0.35
Sep 30, 2018 0.24
Jun 30, 2018 0.40
Mar 31, 2018 0.53
Dec 31, 2017 0.54
Sep 30, 2017 0.69
Jun 30, 2017 0.90